We are live on ! Find out more
GMED icon

Globus Medical

449 hedge funds and large institutions have $7.74B invested in Globus Medical in 2024 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 147 increasing their positions, 176 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $3.38M

2% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 52

0% more capital invested

Capital invested by funds: $7.72B → $7.74B (+$15.6M)

0% less funds holding

Funds holding: 450449 (-1)

4.38% less ownership

Funds ownership: 100.09%95.72% (-4.4%)

16% less repeat investments, than reductions

Existing positions increased: 147 | Existing positions reduced: 176

18% less funds holding in top 10

Funds holding in top 10: 2218 (-4)

Holders
449
Holders Change
-1
Holders Change %
-0.22%
% of All Funds
6.45%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.26%
New
53
Increased
147
Reduced
176
Closed
52
Calls
$13.5M
Puts
$3.38M
Net Calls
+$10.2M
Net Calls Change
-$2.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$760M -$3.55M -50,330 -0.5%
BlackRock
2
BlackRock
New York
$735M -$4.67M -66,166 -0.6%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$501M -$27.3M -387,222 -5%
State Street
4
State Street
Massachusetts
$255M +$5.74M +81,371 +2%
JP Morgan Chase
5
JP Morgan Chase
New York
$186M -$2.19M -31,077 -1%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$184M -$44.6M -631,239 -20%
BAM
7
Burgundy Asset Management
Ontario, Canada
$184M +$4.23M +59,887 +2%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$169M -$17.8M -252,570 -10%
SC
9
Sculptor Capital
New York
$158M
HRCM
10
Hawk Ridge Capital Management
California
$156M -$13.6M -192,360 -8%
CCM
11
Camber Capital Management
Massachusetts
$154M -$24.7M -350,000 -14%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$135M +$1.55M +21,935 +1%
Norges Bank
13
Norges Bank
Norway
$131M +$1.38M +19,528 +1%
CIP
14
Champlain Investment Partners
Vermont
$128M -$47.4M -671,821 -27%
GKIM
15
GW&K Investment Management
Massachusetts
$125M -$517K -7,322 -0.4%
GCM
16
Geneva Capital Management
Wisconsin
$114M +$1.28M +18,117 +1%
Citadel Advisors
17
Citadel Advisors
Florida
$114M +$56.9M +806,296 +103%
William Blair Investment Management
18
William Blair Investment Management
Illinois
$113M -$33.9M -480,356 -23%
Axa
19
Axa
France
$104M -$1.27M -18,034 -1%
VBA
20
Van Berkom & Associates
Quebec, Canada
$104M -$2M -28,401 -2%
MF
21
Magnetar Financial
Illinois
$103M -$20.1M -285,065 -17%
PCM
22
Parsifal Capital Management
Connecticut
$96.6M +$32M +453,053 +50%
Select Equity Group
23
Select Equity Group
New York
$91.8M -$3.97M -56,188 -4%
Charles Schwab
24
Charles Schwab
California
$88.6M +$20.1M +285,172 +30%
MAP
25
Madison Avenue Partners
New York
$81.3M -$19.7M -279,118 -20%

GMED Hedge Fund Activity: Q3 2024 in Review

449 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2024, worth a combined $7.74B — up 0.2% from $7.72B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new GMED positions and 52 closed out — a net gain of 1 holder — while 147 added to existing stakes and 176 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $56.9M. The largest seller was Vestal Point Capital, exiting entirely with an estimated $61.6M sold.

  • 449 institutional investors held Globus Medical (GMED) as of Q3 2024, down from 450 in Q2 2024.
  • Funds reported $7.74B of Globus Medical stock for Q3 2024, up 0.2% quarter-over-quarter.
  • 53 funds opened new Globus Medical positions in Q3 2024 and 52 closed out, a net change of +1 holder.
  • The largest Globus Medical buyer in Q3 2024 was Citadel Advisors, an estimated $56.9M added.
  • The largest Globus Medical seller in Q3 2024 was Vestal Point Capital, an estimated $61.6M sold.

Based on aggregated 13F filings for Q3 2024.